Meghan Horn, MD | |
1500 E Medical Center Drive, 1h247 University Hospital, Ann Arbor, MI 48109-5048 | |
(734) 936-4280 | |
Not Available |
Full Name | Meghan Horn |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Experience | 12 Years |
Location | 1500 E Medical Center Drive, Ann Arbor, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003172065 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 4301102503 (Michigan) | Primary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Michigan Health System | Ann arbor, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
Oragenics has announced that the US Patent office has issued a fourth patent (No. 7,067,125), that further describes the composition and uses of the company's exclusively licensed novel antibiotic peptide, MU1140.
Medicare patients received better care at the University of Michigan Health System, and U-M staff have saved more than $22 million on the cost of that care during a five-year demonstration project.
Researchers at Linköping University have developed in collaboration with French colleagues a small device that both detects the initial signal of an epileptic attack and doses a substance that effectively stops it.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.
› Verified 5 days ago
Entity Name | Regents Of The University Of Michigan |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205868353 PECOS PAC ID: 3779496856 Enrollment ID: O20031106000325 |
News Archive
Oragenics has announced that the US Patent office has issued a fourth patent (No. 7,067,125), that further describes the composition and uses of the company's exclusively licensed novel antibiotic peptide, MU1140.
Medicare patients received better care at the University of Michigan Health System, and U-M staff have saved more than $22 million on the cost of that care during a five-year demonstration project.
Researchers at Linköping University have developed in collaboration with French colleagues a small device that both detects the initial signal of an epileptic attack and doses a substance that effectively stops it.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Meghan Horn, MD 3621 S State St, 700 Kms Place, Ann Arbor, MI 48108 Ph: (734) 936-2047 | Meghan Horn, MD 1500 E Medical Center Drive, 1h247 University Hospital, Ann Arbor, MI 48109-5048 Ph: (734) 936-4280 |
News Archive
Oragenics has announced that the US Patent office has issued a fourth patent (No. 7,067,125), that further describes the composition and uses of the company's exclusively licensed novel antibiotic peptide, MU1140.
Medicare patients received better care at the University of Michigan Health System, and U-M staff have saved more than $22 million on the cost of that care during a five-year demonstration project.
Researchers at Linköping University have developed in collaboration with French colleagues a small device that both detects the initial signal of an epileptic attack and doses a substance that effectively stops it.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.
› Verified 5 days ago
Paul Derek Fernandes, BM Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, 1h247 University Hospital, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Thomas F Curran, Anesthesiology Medicare: Medicare Enrolled Practice Location: 2215 Fuller Rd, Ann Arbor, MI 48105 Phone: 734-845-5342 | |
Youssef Daklallah, Anesthesiology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 313-525-1834 | |
Austin Michael Foote, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Andrew James Baldock, BM Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, 1h247 University Hospital, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Monn Y Lee, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, 1h247 University Hospital, Ann Arbor, MI 48109 Phone: 734-936-4280 |